News

As Seen In
Vancouver hair-loss biotech wins Japanese patent
BUSINESS IN VANCOUVER ARTICLE PUBLISHED ON JANUARY 13, 2014 Vancouver-based RepliCel Life Sciences Inc., a...
Events
RepliCel Life Sciences to Present at Biotech Showcase™ 2014
Vancouver, Canada – January 9, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CSE: RP),...
Press Release
RepliCel to Commence Trading on the TSX Venture Exchange
VANCOUVER, BC – January 9, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CSE: RP)...
Press Release
RepliCel Announces Conditional Approval from TSX Venture Exchange
VANCOUVER, BC – January 2, 2014 –RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCQB:...
Press Release
RepliCel Reports Progress on Shiseido Technology Transfer for RCH-01 Treatment for Pattern Baldness
VANCOUVER, BC – December 19, 2013 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CNSX: RP)...
Press Release
RepliCel Reports Third Quarter 2013 Financial Results and Provides Corporate Update
VANCOUVER, BC – November 20, 2013 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CNSX: RP),...
As Seen In
A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss
The cure for baldness? It could be closer than you think — i.e. among the...
Press Release
RepliCel Forms Clinical Advisory Board to Support the Development of RCT-01 for the Treatment of Chronic Tendinosis
VANCOUVER, BC – October 30, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...
As Seen In
Stem Cell Technology Used in Search for the Holy Grail of Hair Treatments: a Cure for Baldness
Hisae Nakamura, director of research and development for RepliCel, with a device used to inject...
Press Release
RepliCel Announces Stock Option Grant
VANCOUVER, BC – September 6, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...
Press Release
RepliCel Retains Westwicke Partners as Investor Relations Counsel
VANCOUVER, BC – September 4, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...
Press Release
RepliCel Announces Closing of Private Placement
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
Replicel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness
VANCOUVER, BC – July 11, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
Tokyo, Japan and Vancouver, Canada – May 29, 2013 – RepliCel Life Sciences Inc. (the...
Events
Dr. Jerry Shapiro to Present RepliCel Data to European Academy of Dermatology and Venereology in Poland
VANCOUVER, BC – May 23, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel Announces Closing of Private Placement
VANCOUVER, BC – May 21, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise
VANCOUVER, BC – April 30, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Events
RepliCel Presents Further Clinical Data and Corporate Update at its Annual General Meeting of Shareholders
VANCOUVER, BC – June 11, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
As Seen In
Vancouver Biotech Receives U.S. Patent for Hair Regeneration Technology
By Emma Crawford, Thu Apr 18, 2013 10:53am PSTVancouver biotech RepliCel Life Sciences Inc. (OTCQB:REPCF)(CNSX:RP)...
Press Release
RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for its Hair Regeneration Technology
VANCOUVER, BC – April 18, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.